Cause of death, by non-communicable diseases, ages 60+, female in North America
North America: Cause of death, by non-communicable diseases, ages 60+, female was 82.7% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 60+, female in North America, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 60+.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 60+, female in North America is 82.7%, measured in 2021.
The figure is down 10.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, female in North America peaked at 92.4% in 2000 and was at its lowest, 82.7%, in 2020.
North America ranks 6th of 47 groups on this measure, in the top quarter.
Cause of death, by non-communicable diseases, ages 60+, female in North America, year by year
| Year | % of total female deaths ages 60+ | Change |
|---|---|---|
| 2000 | 92.4% | — |
| 2010 | 92.2% | -0.1% |
| 2015 | 91.7% | -0.5% |
| 2019 | 92.0% | +0.3% |
| 2020 | 82.7% | -10.1% |
| 2021 | 82.7% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.4% | 92.4% | 92.4% | 1 |
| 2010s | 92.0% | 91.7% | 92.2% | 3 |
| 2020s | 82.7% | 82.7% | 82.7% | 2 |
Countries ranked near North America
- 3 Turkmenistan 93.3% compare
- 4 Iceland 92.3% compare
- 5 Australia 91.9% compare
- 6 New Zealand 91.4% compare
- 7 Samoa 91.3% compare
- 8 Uzbekistan 91.3% compare
- 9 Micronesia (country) 89.8% compare
More health data for North America
- Population ages 55-59, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0297 units per person (2025)
- Population ages 55-59, male, annual growth rate -0.5946 % change on previous year (2025)
- Population ages 15-19, female, per capita 0.0314 units per person (2025)
- Population ages 60-64, female, annual growth rate -0.6806 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, annual growth rate 0.3175 % change on previous year (2025)
- Population ages 55-59, male, per capita 0.0301 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, female in North America?
- Cause of death, by non-communicable diseases, ages 60+, female in North America was 82.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, female recorded in North America?
- The highest recorded value was 92.4% in 2000.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, female recorded in North America?
- The lowest recorded value was 82.7% in 2020.
- How does North America rank for cause of death, by non-communicable diseases, ages 60+, female?
- North America ranks 6th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, female rising or falling in North America?
- Over the last ten years it is down 10.3%. The long-run trend across the full record is falling.
- Where does this North America data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.